Literature DB >> 2043047

Reproductive toxicity and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Problem of paternally-mediated abnormalities in the progeny of rat.

I Chahoud1, R Krowke, G Bochert, B Bürkle, D Neubert.   

Abstract

Possible effects on the next generation after long-term exposure (subcutaneous administration) of male rats to very high doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) were studied. Two dose regimes were applied: TCDD-25 (initial dose: 25 micrograms/kg body wt; maintenance dose: 5 micrograms/kg body wt, once weekly) and TCDD-75 (initial dose: 75 micrograms/kg body wt; maintenance dose: 15 micrograms/kg body wt). Male rats were treated for 10 weeks before mating and then throughout the entire 12 week mating period. They were mated to unexposed virgin females. One group of pregnant females was used for teratological evaluations, and another group was allowed to deliver. No significant differences were observed in the number of implantations or fetuses per litter, and resorption rate, and fetal weight between the controls and TCDD-treated groups. No gross-structural anomalies occurred in any of the fetuses sired by TCDD-treated males. In the TCDD-25 group an increased frequency of two types of variations was observed which also occur in controls: incompletely ossified fingers (TCDD-25 = 5.1%, controls = 2.6%), and incompletely ossified ossa zygomatica (TCDD-25 = 1.8%, controls = 0.5%). In the TCDD-25 group a slight but statistically significant increase was observed in the rate of stillbirths (TCDD-25 = 1.3%, controls = 0.1%), apparently due to an unusually low frequency occurring in the controls (overall historical controls = 0.6%). There was no difference in postnatal mortality (TCDD-25 = 1.3%, controls = 1.3%). Taken together, despite the very high doses of TCDD used, the data do not provide evidence for biologically significant paternally-mediated developmental toxicity in the fetuses and newborn.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043047     DOI: 10.1007/bf01973499

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Dominant mutations affecting the skeleton in offspring of x-irradiated male mice.

Authors:  U H Ehling
Journal:  Genetics       Date:  1966-12       Impact factor: 4.562

2.  Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice. I. Plan, summary of results and discussion.

Authors:  P B Selby; P R Selby
Journal:  Mutat Res       Date:  1977-06       Impact factor: 2.433

3.  Increased incidence of abnormal foetuses in the offspring of cyclophosphamide-treated male mice.

Authors:  P C Jenkinson; D Anderson; S D Gangolli
Journal:  Mutat Res       Date:  1987-05       Impact factor: 2.433

4.  Agent Orange and risks to reproduction: the limits of epidemiology.

Authors:  M C Hatch; Z A Stein
Journal:  Teratog Carcinog Mutagen       Date:  1986

5.  Vietnam and birth defects.

Authors:  B B Dan
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

6.  Vietnam veterans' risks for fathering babies with birth defects.

Authors:  J D Erickson; J Mulinare; P W McClain; T G Fitch; L M James; A B McClearn; M J Adams
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

7.  Transfer of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) via placenta and through milk in a marmoset monkey.

Authors:  H Hagenmaier; T Wiesmüller; G Golor; R Krowke; H Helge; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 8.  Does Agent Orange cause birth defects?

Authors:  J M Friedman
Journal:  Teratology       Date:  1984-04

9.  Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice. II. Description of proved mutations.

Authors:  P B Selby; P R Selby
Journal:  Mutat Res       Date:  1978-08       Impact factor: 2.433

10.  Survey of reproductive events of wives of employees exposed to chlorinated dioxins.

Authors:  J C Townsend; K M Bodner; P F Van Peenen; R D Olson; R R Cook
Journal:  Am J Epidemiol       Date:  1982-05       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.